Record margin, but revenue growth falters; organic PAT masks EPR windfall
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met margin target (18%+), beat it (21.7% OPM); revenue just at 20% guidance floor; new product ramps on track (TPO Q2, rCB Q3).
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong Q1 margins (21.7% OPM, 13.1% NPM) validate operational strategy; however, revenue growth at guidance floor (19.9% vs 20%+ prior), QoQ revenue down 0.5%, and ~₹5 Cr PAT from one-time EPR monetization mask organic slowdown. Consumer segment weakness (-20% volume) and geopolitical headwinds temper near-term. Long-term (Vision 2029 at ₹1,000 Cr on 25%+ CAGR) is ambitious but execution-dependent.
₹156.2 Cr
Revenue · +19.9% YoY₹20.6 Cr
Reported PAT · +75.2% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
Record EBITDA exceeding ₹30 crores; PAT surpassing ₹20 crores.
METEBITDA ~₹34 Cr (21.7% OPM), PAT ₹20.6 Cr (13.1% NPM). ✓ Supported; highest in at least 2–3 years.
Revenue increased by 18–20% YoY on standalone basis.
MET19.9% YoY growth delivered. ✓ Supported; just below prior 20–25% guidance.
Industrial segment grew 58% YoY in revenue.
OVERSTATEDIndustrial segment volume +27% YoY; revenue benefit from higher realization + MRP/reclaim growth (28%/37% volumes). Mix of volume and value-add; 58% claim likely includes exports (+46%) and new customer adds. Plausible but overstated for core industrial segment.
PCMB revenue increased threefold to ₹12 Cr from ₹4 Cr YoY.
METQ1 FY27 PCMB revenue ₹12 Cr vs Q1 FY26 ₹4 Cr. ✓ Supported. Capacity now 18,000 tpa (up from 6,000 tpa initial).
Margins 18%+ sustainable; no inventory gains.
OVERSTATEDQ1 delivered 21.7% OPM; management guided 18–20% for FY27 (conservative). Material+inventory cost ratio 46% of sales (Q1) vs 51%+ prior year. Margin driven by raw material optimization + value-add mix, not one-offs. But ~₹5 Cr of ₹20.6 Cr PAT from EPR monetization (non-recurring).
Earnings quality
What changed since the last call
FY27 revenue guidance narrowed
DowngradePrior: 20–25% YoY growth. Q1 delivered 19.9% YoY; management guided ₹670–700 Cr FY27 revenue (~16–17% growth for full year), implying deceleration after strong ramps in Q2–Q3.
Margin guidance conservative
NeutralPrior: 18%+ EBITDA target. Q1 delivered 21.7% OPM; guidance reset to 18–20%, citing front-ended expansion costs. Suggests 18–20% is sustainable midpoint, not 21%+.
Consumer segment impact
DowngradeNot called out in prior guidance. Q1 volume down 20% due to raw material cost shocks; management expects recovery when market stabilizes, but timing unclear.
International investments ramping
NewSouth Africa, Saudi, Chile now active (₹27 Cr capex Q1). Prior guidance indicated international as hedge; now visible cost drag on near-term margins.
The Q&A
Moderate pressure on margins and EPR accounting; analysts pressed on sustainability of 21%+ margins (management deflected to 18–20% guidance), EPR's P&L treatment (management clarified one-time vs recurring), and near-term headwinds (geopolitical, monsoon delays). Management held firm on Vision 2029 roadmap; tone was confident but evasive on geopolitical risks.
Margin sustainability — Dheeraj Ram, 360 ONE Capital
PartialInventory gains marginal. Margin expansion from raw material optimization and value-add product mix (systemic, not one-off). Expect 18–20% blended for year due to expansion capex costs.
EPR accounting — Deepak Poddar, Sapphire Capital
AnsweredMonetized 100k units from prior years' accrual. Recurring EPR ₹25–30 Cr annually at PBT level. This quarter's ₹25 Cr converted to cash; impact already in prior P&L.
Geopolitical and expansion risk — Mihir, Equirus
DodgedDetails confidential. Chile and South Africa secure tire supply hedge. Saudi a natural extension of Oman base. Core investment remains India. ₹100 Cr FY27–28 plan; may increase if demand strong.
Infra segment outlook — Mihir, Equirus
AnsweredBitumen shortage actually helped (contractors prefer cheaper rubberized bitumen). Q1 is peak season; Q2 typically weak (monsoon). But using modified bitumen to work through. Demand momentum expected to hold.
Consumer segment recovery — Navani Naredi, Naredi Investment
PartialConsumer 8–10% of revenue; hedge is diversification across industrial, infra, steel, PCMB, TPO, rCB. Price issue is with binder (outside control). Business intact; demand there.
EPR P&L treatment — Viraj, MoneyGrow
Partial₹156 Cr includes Q1 accrued EPR income only. ₹20.6 Cr PAT includes ₹5 Cr from prior year EPR monetization. Two different things; cannot mix.
Organic profitability — Ajit Sethi, investor
DodgedNumbers correct, but EPR is integral to recycling business, not separable. Treat it as core earnings.
FY27 guidance — Saurav Gupta, investor
AnsweredFY27 revenue ₹670–700 Cr; EBITDA margins 18–20%. Q1 22% not repeatable; guidance conservative to cover expansion costs.
Margin decomposition — Amit Rathi, Capital
PartialMain contribution gross margin (raw material optimization + value-add sales). Some efficiencies from scale. Cannot isolate exact numbers.
Guidance
FY27 revenue ₹670–700 Cr
HighQ1 ₹156 Cr × 4 = ₹624 Cr annualized, but Q2–Q4 expected higher as TPO/rCB ramp. Implies ₹670–700 Cr achievable; ~16–17% FY growth.
EBITDA margins 18–20% for FY27
HighConservative relative to Q1's 21.7% OPM. Accounts for expansion capex (front-ended costs), new geographies (South Africa, Saudi early losses), and normalization of one-time benefits.
₹100 Cr over FY27–28 (₹60 Cr FY27, ₹40 Cr FY28)
HighPartially funded by internal accruals; limited debt possible. Covers MRP expansion (+3.5k tpa), TPO, rCB, PCMB expansion, international sites.
Risks the call surfaced
Geopolitical exposure
HighBitumen shortage created near-term demand boost (rubberized bitumen), but sustained disruption could choke infra segment (7% YoY growth). Saudi facility start delayed by geopolitical normalization need. Oman margins recovering post-crisis.
Consumer segment weakness
MediumConsumer segment (8–10% of revenue) down 20% volume in Q1 due to binder/synthetic grass price spikes. Contractors delaying turfing projects. Recovery timeline unspecified; demand may take quarters to normalize.
Margin sustainability
MediumManagement guided 18–20% EBITDA for FY27 (vs Q1's 21.7% OPM), citing expansion capex, new geographies, and one-time benefits. Risk that margins normalize below Q1 as new plants ramp and geopolitical benefits fade.
One-time EPR benefit inflating PAT
MediumQ1 PAT ₹20.6 Cr includes ~₹5 Cr from prior year EPR credit monetization (accrual taken in prior years). Organic PAT ~₹15.6 Cr (10% NPM). Recurring EPR ₹25–30 Cr at PBT level (not PAT), so Q1 organic growth overstated.
International expansion execution
HighSouth Africa Phase 1 completed Q1, breakeven expected Q2; Phase 2 (9k tpa crumb rubber) equipment en route, production Q2–Q3. Saudi facility start delayed pending geopolitical normalization. Chile subsidiary established but strategic details withheld. Collective ₹27 Cr capex Q1 is early-stage investment; profitability unproven.
Management
Score 6/10. Clear on strategy and capex roadmap; detailed on segment performance. Evasive on geopolitical risks and Chile rationale ('details confidential'). Defensive on EPR accounting and margin sustainability. Met FY26 guidance; Q1 delivered margin target (18%+ guidance vs 21.7% delivered). Revenue growth 19.9% YoY just at guidance floor (20%+). Capex on track (₹27 Cr Q1 vs ₹60 Cr FY27 plan). New products launching (TPO Q2, rCB Q3). Mixed track record.
1 · Q2 FY27 (Jul–Sep 2026)
TPO facility commercial sales launch; rCB production to start Q3.
2 · Q3 FY27 (Oct–Dec 2026)
MRP capacity +3,500 tpa to 20,000 tpa commissioned; rCB production ramp.
3 · FY27 closing (Mar 2027)
Management targeting ₹670–700 Cr revenue, 18–20% EBITDA margins.
Long-term (Vision 2029 at ₹1,000 Cr on 25%+ CAGR) is ambitious but execution-dependent.
Informational and educational content only. Not investment advice.